知情同意领域的新机遇与威胁

Clinical researcher (Alexandria, Va.) Pub Date : 2016-02-01 DOI:10.14524/CR-16-4005

James Michael Causey

{"title":"知情同意领域的新机遇与威胁","authors":"James Michael Causey","doi":"10.14524/CR-16-4005","DOIUrl":null,"url":null,"abstract":"Informed consent errors have fallen to sixth from first place as cited in most common clinical investigator findings by the U.S. Food and Drug Administration (FDA) over the past five years. While that suggests clinical researchers and sites have gotten better at handling this critically important","PeriodicalId":90809,"journal":{"name":"Clinical researcher (Alexandria, Va.)","volume":"21 1","pages":"40-41"},"PeriodicalIF":0.0000,"publicationDate":"2016-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New Opportunities and Threats in the Realm of Informed Consent\",\"authors\":\"James Michael Causey\",\"doi\":\"10.14524/CR-16-4005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Informed consent errors have fallen to sixth from first place as cited in most common clinical investigator findings by the U.S. Food and Drug Administration (FDA) over the past five years. While that suggests clinical researchers and sites have gotten better at handling this critically important\",\"PeriodicalId\":90809,\"journal\":{\"name\":\"Clinical researcher (Alexandria, Va.)\",\"volume\":\"21 1\",\"pages\":\"40-41\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical researcher (Alexandria, Va.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14524/CR-16-4005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical researcher (Alexandria, Va.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14524/CR-16-4005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

美国食品和药物管理局(FDA)在过去五年中最常见的临床研究发现中，知情同意错误从第一位下降到第六位。虽然这表明临床研究人员和网站在处理这一至关重要的问题方面做得更好

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

New Opportunities and Threats in the Realm of Informed Consent

Informed consent errors have fallen to sixth from first place as cited in most common clinical investigator findings by the U.S. Food and Drug Administration (FDA) over the past five years. While that suggests clinical researchers and sites have gotten better at handling this critically important

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical researcher (Alexandria, Va.)

自引率

0.00%

发文量